ALLO - Allogene Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALLO is currently covered by 16 analysts with an average price target of $15.89. This is a potential upside of $13.06 (461.48%) from yesterday's end of day stock price of $2.83.

Allogene Therapeutics's activity chart (see below) currently has 96 price targets and 110 ratings on display. The stock rating distribution of ALLO is 81.4% BUY, 16.28% HOLD and 2.33% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25.4% with an average time for these price targets to be met of 80.79 days.

Highest price target for ALLO is $17, Lowest price target is $4.6, average price target is $15.89.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 16-May-2024. First documented stock forecast 05-Nov-2018.

Currently out of the existing stock ratings of ALLO, 35 are a BUY (81.4%), 7 are a HOLD (16.28%), 1 are a SELL (2.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

9

$6.24 (226.09%)

10

2 months 3 days ago

0/6 (0%)

$5.99 (199.00%)

Buy

17

$14.24 (515.94%)

2 months 4 days ago

2/10 (20%)

$14.02 (470.47%)

94

Hold

4.6

$1.84 (66.67%)

5

2 months 5 days ago

3/8 (37.5%)

$1.64 (55.41%)

11

Buy

8

$5.24 (189.86%)

9

4 months 22 days ago

0/3 (0%)

$2.86 (55.64%)

Buy

10

$7.24 (262.32%)

12

6 months ago

1/7 (14.29%)

$6.91 (223.62%)

28

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALLO (Allogene Therapeutics) average time for price targets to be met?

On average it took 80.79 days on average for the stock forecasts to be realized with a an average price target met ratio 25.4

Which analyst has the current highest performing score on ALLO (Allogene Therapeutics) with a proven track record?

MARK BREIDENBACH

Which analyst has the most public recommendations on ALLO (Allogene Therapeutics)?

Mark Breidenbach has 4 price targets and 2 ratings on ALLO

Which analyst is the currently most bullish on ALLO (Allogene Therapeutics)?

Luca Issi with highest potential upside - $29.24

Which analyst is the currently most reserved on ALLO (Allogene Therapeutics)?

Dane Leone with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?